ENvue Medical (FEED) Cash from Operations Growth (3y) (2017 - 2026)
ENvue Medical (FEED) Cash from Operations Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 129.50 Bn | 126.03 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 119.85 Bn | 110.63 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 73.79 Bn | 73.25 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 34.58 Bn | 32.64 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 34.14 Bn | 32.03 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.23 Bn | 22.74 Bn | 684.20 Mn | 9.30% |
| 10 | ENvue Medical | 2.48 Mn | 1.33 Mn | -266,000.00 | -29.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.85% |
| Mar 31, 2026 | -53.17% |
| Dec 31, 2025 | -26.21% |
| Sep 30, 2025 | -0.10% |
| Jun 30, 2025 | -19.17% |
| Mar 31, 2025 | 8.29% |
| Dec 31, 2024 | 14.05% |
| Sep 30, 2024 | -9.66% |
| Jun 30, 2024 | 33.91% |
| Mar 31, 2024 | 15.33% |
| Dec 31, 2023 | 28.05% |
| Sep 30, 2023 | 0.63% |
| Jun 30, 2023 | -36.52% |
| Mar 31, 2023 | -10.27% |
| Dec 31, 2022 | -8.85% |
| Sep 30, 2022 | -20.84% |
| Jun 30, 2022 | -36.15% |
| Mar 31, 2022 | -22.94% |
| Dec 31, 2021 | 0.69% |
| Sep 30, 2021 | 7.34% |